Financial Data and Key Metrics Changes - In Q4 2025, the company achieved 6% organic growth, with an adjusted operating margin expansion of 80 basis points, and adjusted EPS of $8.12, reflecting a 13% increase year-over-year when excluding TRANZACT [5][18] - For the full year, organic growth was 5%, with adjusted operating margin expanding by 130 basis points to 25.2%, and adjusted diluted EPS of $17.08, also up 13% year-over-year excluding TRANZACT [5][18] Business Line Data and Key Metrics Changes - Health, Wealth and Career (HWC) segment saw organic growth accelerate to 6% in Q4, with a full-year growth of 4% [5][19] - Risk and Broking (R&B) generated 7% organic growth in Q4, with corporate Risk and Broking achieving 8% growth, marking the 12th consecutive quarter of high single-digit growth [6][25] - The insurance consulting and technology business experienced a decline of 1% in Q4, with full-year growth at 1% compared to 4% the previous year [26] Market Data and Key Metrics Changes - The international market drove growth in the health segment, particularly in Europe, while North America faced challenges due to a book of business sale in the prior year [20] - The company expects strong demand across global markets, driven by healthcare inflation and employers' focus on managing costs while maintaining competitive employee benefits [20][66] Company Strategy and Development Direction - The company is focused on optimizing its portfolio through strategic acquisitions, including Newfront, Cushon, and FlowStone Partners, to enhance growth and profitability [4][15] - The specialization strategy in Risk and Broking continues to drive new business momentum, particularly in construction and surety [6][25] - Investments in talent and technology are central to the company's strategy, with a focus on enhancing efficiency and driving margin expansion [11][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position and outlook for 2026, anticipating mid-single-digit organic growth and continued margin expansion [16][30] - The political and regulatory environment remains dynamic, prompting clients to seek the company's advice and solutions [16] - While optimistic about current conditions, management is monitoring potential headwinds for the upcoming year [16] Other Important Information - The company generated free cash flow of $1.5 billion for the year, with a free cash flow margin of 15.9%, an increase from 12.8% the previous year [31] - Share repurchases are a primary method of capital return, with at least $1 billion expected to be allocated to buybacks in 2026 [32] Q&A Session Summary Question: Drivers of organic growth within R&B - Management highlighted strong organic growth of 7% in R&B, driven by specialization strategy and investments in talent, data, and technology [37][39] Question: Mid- to high single-digit guidance for R&B in 2026 - Management acknowledged that while pricing may improve, growth is supported by high retention rates and new business opportunities, particularly in digital infrastructure and electrification [40][42] Question: Impact of talent on organic growth in 2026 - The company plans to continue strategic hiring to support organic growth, emphasizing the importance of talent in driving sustainable and profitable growth [52][54] Question: Changes in Medicare influencing BD&O growth - Management expects modest headwinds from Medicare changes but anticipates strong demand for retiree marketplace services to support low single-digit growth in 2026 [60][61] Question: AI's impact on consulting services - Management views AI as an opportunity rather than a threat, focusing on regulatory-driven recurring services that are expected to remain in demand [74]
Willis Towers Watson(WTW) - 2025 Q4 - Earnings Call Transcript